Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

26.46 +0.20 (+0.76%)
Streaming Delayed Price Updated: 10:04 AM EDT, Apr 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,262,402
Open 26.33
Bid (Size) 26.45 (52)
Ask (Size) 26.46 (11)
Prev. Close 26.26
Today's Range 26.26 - 26.46
52wk Range 25.23 - 40.36
Shares Outstanding 5,606,688,356
Dividend Yield 6.20%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Better Buy: Pfizer vs. Viking Therapeutics
These two pharma stocks have followed distinct paths of late. Which is the better investment? 
Via The Motley Fool
1 No-Brainer Vanguard Fund to Buy Right Now
This Vanguard growth fund is home to some of the world's most innovative companies. 
Via The Motley Fool

Performance

YTD
-11.00%
-11.00%
1 Month
-3.54%
-3.54%
3 Month
-6.53%
-6.53%
6 Month
-14.20%
-14.20%
1 Year
-33.70%
-33.70%

More News

Read More
US Stock: Pfizer
Via Talk Markets
3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years
Via InvestorPlace
Pfizer Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Wednesday Trading
Via Investor Brand Network
Exposures COVID-19
A Closer Look at Pfizer's Options Market Dynamics
Via Benzinga
Is Pfizer Stock a Buy?
Via The Motley Fool
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
From Pfizer Inc.
Via Business Wire
Capturing Consumer Spending on Health Care with XLV
Via News Direct
3 Stocks Under $50 You Can Buy Hand Over Fist Right Now
Via The Motley Fool
If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today
Via The Motley Fool
The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback
Via InvestorPlace
3 No-Brainer Stocks to Buy With $100 Right Now
Via The Motley Fool
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
Via Benzinga
Pneumococcal Pneumonia Vaccination Can Save Your Life
Via StatePoint Media
Better Growth Play: Merck or The Vanguard Growth Index Fund?
Via The Motley Fool
Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.
Via The Motley Fool
The Smartest Dividend Stocks to Buy With $400 Right Now
Via The Motley Fool
QFunction: Cybersecurity Company Announces Launch of Customized AI Solutions
Via Press Release Distribution Service
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever
Via The Motley Fool
Is Pfizer Stock the Biggest Bargain in the S&P 500?
Via The Motley Fool
Topics Stocks
Exposures US Equities
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
Via InvestorPlace
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
From Pfizer Inc.
Via Business Wire
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.